Carrageenan-based gel retains limited anti-HIV-1 activity 8-24 hours after vaginal application by HIV-infected Thai women enrolled in a phase I safety trial.
作者信息
Haaland Richard E, Chaowanachan Thanyanan, Evans-Strickfaden Tammy, van de Wijgert Janneke H, Kilmarx Peter H, McLean Catherine A, Hart Clyde E
出版信息
J Acquir Immune Defic Syndr. 2012 Dec 15;61(5):e71-3. doi: 10.1097/QAI.0b013e318271c8f9.